HOME > TOP STORIES
TOP STORIES
-
REGULATORY Industry Chiefs, Chuikyo Panelists Trade Barbs over Market Expansion on Add’l Indications
September 15, 2016
-
BUSINESS Novartis Eager to See More 1st Approvals in Japan despite Pricing Headache
September 14, 2016
-
REGULATORY Blue Book “Will Be Used as Reference When Selecting Generics”: Panel Chair
September 14, 2016
-
REGULATORY G7 Health Ministers Adopt Kobe Communique
September 13, 2016
-
REGULATORY Generics from 5 Companies Enough When Major Products Lose Patent Protection: Top Bureaucrat
September 13, 2016
-
BUSINESS Nippon Shinyaku on Track to Achieve Targets in Midterm Plan with Sales of Selexipag Above Expectations: President
September 12, 2016
-
REGULATORY MHLW Panel Backs BI’s Triple Combo After 3rd Try
September 9, 2016
-
BUSINESS Biogen Japan’s Hemophilia Spinoff to Be Up and Running in Early 2017
September 8, 2016
-
ORGANIZATION Kenporen’s Kono Pushes for “Huge Seller” Re-Pricing for Opdivo before 2018
September 7, 2016
-
REGULATORY 6 National Centers Log Generic Use Rate of Average 73.8% in FY2015
September 6, 2016
-
BUSINESS Oncolys to Evaluate Oncolytic Virus in Combination with Immune Checkpoint Inhibitors; Interim Results Expected in 2017
September 5, 2016
-
BUSINESS Otsuka, RIKEN Open Collaborative Research Center to Promote Regenerative Medicine
September 2, 2016
-
BUSINESS Harvoni Outstrips Plavix to Top FY2015 Japan Sales Ranking: Jiho Tally
September 1, 2016
-
REGULATORY Lilly Drops Listing of Taltz amid Pricing Fuss, Wants to Deliver Drug without Restrictions
August 31, 2016
-
REGULATORY MHLW Panel to Discuss Keytruda on Sept. 9, Listing Expected as Early as November
August 30, 2016
-
BUSINESS Sizzling DOAC Market - 4: Companies Aim to Differentiate Their Products through Quality of Information
August 29, 2016
-
BUSINESS Sizzling DOAC Market - 3: Dosage and Administration Vary by Product for PE/DVT Treatment
August 26, 2016
-
REGULATORY Chuikyo Subcommittee Effectively Kicks Off Debates on FY2018 Reform, with Focus on Pricy Meds
August 25, 2016
-
REGULATORY After Taltz Given High Price, MHLW to Push Use of Other Psoriasis Drugs; Revision to Foreign Price Adjustment Eyed
August 25, 2016
-
REGULATORY Chuikyo OKs Praluent, 8 Other APIs for Listing on Aug. 31
August 24, 2016
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
